Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebrovascular Circulation | 13 | 2024 | 2727 | 1.800 |
Why?
|
Alzheimer Disease | 11 | 2024 | 8599 | 0.950 |
Why?
|
tau Proteins | 7 | 2024 | 2095 | 0.750 |
Why?
|
Amyloidosis | 2 | 2024 | 817 | 0.690 |
Why?
|
Magnetic Resonance Imaging | 22 | 2024 | 36426 | 0.640 |
Why?
|
Apolipoproteins E | 1 | 2024 | 1444 | 0.620 |
Why?
|
Appetite | 1 | 2020 | 247 | 0.600 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2023 | 895 | 0.600 |
Why?
|
Pulsatile Flow | 1 | 2018 | 321 | 0.570 |
Why?
|
Brain | 15 | 2024 | 27112 | 0.540 |
Why?
|
Hormones | 1 | 2020 | 869 | 0.520 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1866 | 0.390 |
Why?
|
Spin Labels | 6 | 2022 | 337 | 0.390 |
Why?
|
Presenilin-1 | 3 | 2024 | 660 | 0.380 |
Why?
|
Cognition | 5 | 2024 | 6990 | 0.360 |
Why?
|
Genotype | 1 | 2024 | 12990 | 0.330 |
Why?
|
Cerebrovascular Disorders | 1 | 2015 | 1474 | 0.300 |
Why?
|
Parkinson Disease | 2 | 2018 | 2877 | 0.280 |
Why?
|
Dementia | 3 | 2019 | 2686 | 0.270 |
Why?
|
Movement | 1 | 2013 | 1478 | 0.260 |
Why?
|
Amyloid beta-Peptides | 6 | 2024 | 3839 | 0.240 |
Why?
|
Aging | 1 | 2024 | 8708 | 0.240 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 9000 | 0.210 |
Why?
|
Amyloidogenic Proteins | 1 | 2023 | 151 | 0.210 |
Why?
|
Bipolar Disorder | 2 | 2016 | 5092 | 0.190 |
Why?
|
Leukoaraiosis | 1 | 2022 | 116 | 0.180 |
Why?
|
DiGeorge Syndrome | 1 | 2022 | 185 | 0.180 |
Why?
|
Aged | 17 | 2024 | 169289 | 0.170 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2024 | 620 | 0.170 |
Why?
|
Glucose Metabolism Disorders | 1 | 2019 | 52 | 0.170 |
Why?
|
Amyloid | 1 | 2024 | 841 | 0.160 |
Why?
|
Atrophy | 1 | 2024 | 1633 | 0.160 |
Why?
|
Parietal Lobe | 3 | 2019 | 852 | 0.160 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14605 | 0.160 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26125 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 3 | 2020 | 1432 | 0.150 |
Why?
|
Male | 22 | 2024 | 360804 | 0.150 |
Why?
|
Aged, 80 and over | 8 | 2024 | 58976 | 0.150 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2019 | 281 | 0.150 |
Why?
|
Lung | 2 | 2013 | 10000 | 0.140 |
Why?
|
Verbal Learning | 1 | 2019 | 463 | 0.140 |
Why?
|
Positron-Emission Tomography | 5 | 2024 | 6485 | 0.140 |
Why?
|
Female | 22 | 2024 | 392644 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9469 | 0.140 |
Why?
|
Humans | 31 | 2024 | 761504 | 0.130 |
Why?
|
Frontotemporal Dementia | 1 | 2019 | 247 | 0.130 |
Why?
|
Cerebral Hemorrhage | 2 | 2023 | 2656 | 0.110 |
Why?
|
Gyrus Cinguli | 2 | 2016 | 1115 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3492 | 0.110 |
Why?
|
Lewy Body Disease | 1 | 2015 | 252 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 1027 | 0.100 |
Why?
|
Hypotension, Orthostatic | 1 | 2015 | 258 | 0.100 |
Why?
|
Metformin | 1 | 2020 | 906 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 1068 | 0.100 |
Why?
|
Double-Blind Method | 2 | 2024 | 12341 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2019 | 868 | 0.100 |
Why?
|
Aorta | 1 | 2020 | 2042 | 0.100 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2013 | 141 | 0.100 |
Why?
|
Rest | 1 | 2016 | 918 | 0.100 |
Why?
|
Lung Neoplasms | 2 | 2013 | 13380 | 0.100 |
Why?
|
Middle Aged | 14 | 2024 | 220895 | 0.090 |
Why?
|
Cohort Studies | 4 | 2023 | 41487 | 0.090 |
Why?
|
Finite Element Analysis | 1 | 2013 | 438 | 0.090 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2016 | 556 | 0.090 |
Why?
|
Hemorrhage | 1 | 2022 | 3424 | 0.090 |
Why?
|
Psychomotor Performance | 1 | 2018 | 1881 | 0.090 |
Why?
|
Cerebral Cortex | 2 | 2016 | 5777 | 0.080 |
Why?
|
Exercise | 2 | 2016 | 5890 | 0.080 |
Why?
|
Corpus Striatum | 1 | 2015 | 1235 | 0.080 |
Why?
|
Observer Variation | 1 | 2015 | 2606 | 0.080 |
Why?
|
Prefrontal Cortex | 1 | 2019 | 2219 | 0.080 |
Why?
|
Adult | 10 | 2024 | 221177 | 0.070 |
Why?
|
Nerve Net | 1 | 2019 | 2290 | 0.070 |
Why?
|
Blood Pressure | 1 | 2023 | 8481 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3223 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20098 | 0.070 |
Why?
|
Swine | 2 | 2013 | 5915 | 0.070 |
Why?
|
Computer Simulation | 2 | 2017 | 6240 | 0.060 |
Why?
|
Pediatrics | 1 | 2020 | 3589 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 5914 | 0.060 |
Why?
|
Phantoms, Imaging | 1 | 2013 | 2526 | 0.060 |
Why?
|
Cognitive Reserve | 1 | 2024 | 92 | 0.060 |
Why?
|
Schizophrenia | 1 | 2022 | 6937 | 0.050 |
Why?
|
Chronic Disease | 2 | 2015 | 9318 | 0.050 |
Why?
|
Stroke | 2 | 2015 | 9757 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 12953 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11903 | 0.050 |
Why?
|
Algorithms | 2 | 2020 | 14031 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2022 | 22176 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8540 | 0.040 |
Why?
|
Young Adult | 4 | 2022 | 59243 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9031 | 0.040 |
Why?
|
Risk Factors | 2 | 2023 | 74206 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
Age of Onset | 1 | 2024 | 3305 | 0.040 |
Why?
|
Obesity | 1 | 2019 | 12947 | 0.040 |
Why?
|
Prospective Studies | 2 | 2019 | 54425 | 0.030 |
Why?
|
Adolescent | 4 | 2020 | 88319 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15500 | 0.030 |
Why?
|
Putamen | 1 | 2016 | 292 | 0.030 |
Why?
|
Occipital Lobe | 1 | 2015 | 374 | 0.030 |
Why?
|
Neurogenesis | 1 | 2020 | 863 | 0.030 |
Why?
|
Mutation | 3 | 2024 | 30052 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2024 | 2400 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2787 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3769 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2022 | 3096 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
Diaphragm | 1 | 2012 | 351 | 0.020 |
Why?
|
Thalamus | 1 | 2016 | 1045 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2016 | 1420 | 0.020 |
Why?
|
Animals | 3 | 2023 | 168459 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2016 | 1695 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9610 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8631 | 0.020 |
Why?
|
Software | 1 | 2020 | 4434 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7045 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10508 | 0.020 |
Why?
|
Brachytherapy | 1 | 2012 | 1223 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5247 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39967 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42230 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81525 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64680 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18252 | 0.010 |
Why?
|
Child | 1 | 2020 | 80153 | 0.010 |
Why?
|
United States | 1 | 2019 | 72334 | 0.010 |
Why?
|
Concepts
(127)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_